Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Radiographic and Patient Outcomes Following Lumbar Spine Fusion Using Demineralized Bone Matrix (DBM) Mixed With Autograft

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient is indicated for primary lumbar fusion of 1 or 2 segments, L2 to S1~* Patient is willing to be blindly randomized to treatment or control and remain blinded for 2 years of follow-up~* Patient is at least twenty-one (21) years of age~* Patient is expected to survive at least 2 years beyond surgery~* Patient is willing to participate by complying with pre- and postoperative visit requirements, including: completion of questionnaires, functional performance tests, and radiographs/CT scan~* Patient is willing and able to review and sign a study Informed Consent form~Exclusion Criteria:~* Patient has a mental or physical condition that would invalidate evaluation results~* Patient is pregnant~* Patient is a prisoner~* Patient has a systemic infection or infection at the proposed surgical site~* Patient has osteopenia, osteoporosis, or osteomalacia to a degree that spinal instrumentation would be contraindicated~* Patient has a disease of bone metabolism~* Patient is undergoing chemotherapy or radiation treatment~* Patient is currently involved in a study of another product for a similar purpose~* Patient requires post-op management with nonsteroidal anti-inflammatory drugs (NSAIDs)

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- O (Type: ACTIVE_COMPARATOR): This treatment arm includes autograft harvested from local bone and / or the iliac crest, supplemented with a demineralized bone matrix (DBM) autograft extender, Optecure.
- A (Type: ACTIVE_COMPARATOR): This treatment arm includes autograft harvested from local bone and / or the iliac crest.

Based on this trial design, predict the completion outcome and termination type (if applicable).